Aurora Europe is a subsidiary of Aurora Cannabis Inc., a global leader in the cannabis industry serving both medical and consumer markets and dedicated to helping people improve their lives. Aurora’s network of EU GMP-certified facilities brings high-quality medical cannabis to patients worldwide. The most recent addition is Aurora’s 1st facility in Europe, a high-tech greenhouse cultivation in Odense, Denmark. You find more information about the company here: www.auroramedicine.com

The animation explains how medical cannabis, dried flowers and extracts, are produced in high-tech production facilities under EU GMP standards. The entire process is defined by strict standard operating procedures and automatically monitored (temperature, air quality, humidity, light duration and intensity). This ensures a consistent quality, which is required for pharmaceutical use.

Cannabis is a medicine. The knowledge about the medical plant is thousands of years old, but it has been forgotten. In the early 1990s, scientists discovered that the brain and the human body have their own "endocannabinoid system" that controls biological functions. THC and CBD control this system. Numerous studies indicate the positive therapeutic effects of medical cannabis in severe diseases such as neuropathic pain, epilepsy, multiple sclerosis and many others. But sleep disorders, depression or anxiety can also be treated.

свернуть